Gaurav Shah, CEO at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 9,534 shares at $15.47 ($147K) on 2023-08-17, disclosed to the SEC on 2023-08-21.
Open-market sale of $147k RCKT by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.47 | 4,767 | $74K | 50.0% |
| 2 | $15.47 | 4,767 | $74K | 50.0% |
| Total | $15.47 avg | 9,534 | $147K | 100% |
| Filing → |
| RCKT | SELL | 2026-05-26 | $172K | — | Filing → |
| RCKT | SELL | 2026-05-21 | $7K | — | Filing → |
| RCKT | SELL | 2026-05-14 | $10K | — | Filing → |